53 results on '"Horibe, Keizo"'
Search Results
2. Flow cytometric analysis as an additional predictive tool of treatment response in children with chronic‐phase chronic myeloid leukemia treated with imatinib
3. Acid-suppressing Drugs and a Low 1 Level of Antithrombin as Risk Factors for L-Asparaginase-associated Pancreatitis: A Case-control Study in the Japan Association of Childhood Leukemia Study (JACLS)
4. Acid-suppressing Drugs and a Low 1 Level of Antithrombin as Risk Factors for L-Asparaginase-associated Pancreatitis: A Case-control Study in the Japan Association of Childhood Leukemia Study (JACLS)
5. Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study
6. Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia
7. Multiplex fusion gene testing in pediatric acute myeloid leukemia
8. Fludarabine, cytarabine, granulocyte colony‐stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia
9. Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial
10. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group
11. Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study
12. Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group
13. Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan
14. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial
15. Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion
16. Predictors of Posttraumatic Stress Symptoms Among Adolescent and Young Adult Survivors of Childhood Cancer: Importance of Monitoring Survivorsʼ Experiences of Family Functioning
17. CSF3R and CALR mutations in paediatric myeloid disorders and the association of CSF3R mutations with translocations, including t(8; 21)
18. General Health Status and Late Effects Among Adolescent and Young Adult Survivors of Childhood Cancer in Japan
19. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group
20. Improved Treatment Results of Children With B-Cell Non-Hodgkin Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 Study
21. Prognostic impact of gained chromosomes in high-hyperdiploid childhood acute lymphoblastic leukaemia: a collaborative retrospective study of the Tokyo Childrenʼs Cancer Study Group and Japan Association of Childhood Leukaemia Study
22. Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia
23. IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia
24. Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003–06 from the Japan Association of Childhood Leukaemia Study
25. De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristics
26. Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
27. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia
28. Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with Chronic Myeloid Leukemia
29. Total body irradiation and melphalan as a conditioning regimen for children with hematological malignancies undergoing transplantation with stem cells from HLA-identical related donors
30. Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature
31. Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: Report of the ALCL99 randomised trial
32. Medical visits of childhood cancer survivors in Japan: A cross-sectional survey
33. Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study
34. Mental health among young adult survivors of childhood cancer and their siblings including posttraumatic growth
35. Survey of childhood cancer survivors who stopped follow-up physician visits
36. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia Study (JACLS) ALL F-protocol
37. Retrospective analysis of relapsed or primary refractory childhood lymphoblastic lymphoma in Japan
38. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma
39. Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma
40. The Role of Hematopoietic Stem Cell Transplantation With Relapsed or Primary Refractory Childhood B-Cell Non-Hodgkin Lymphoma and Mature B-Cell Leukemia: A Retrospective Analysis of Enrolled Cases in Japan
41. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome
42. Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: A study of the Japanese childhood AML Cooperative Study Group
43. Genetic abnormalities involved in t(12;21) TEL–AML1 acute lymphoblastic leukemia: Analysis by means of array-based comparative genomic hybridization
44. Extramedullary Infiltration At Diagnosis and Prognosis in Children With Acute Myelogenous Leukemia
45. Features and Outcome of Neonatal Leukemia in Japan: Experience of the Japan Infant Leukemia Study Group
46. Improved Outcome in the Treatment of Pediatric Multifocal Langerhans Cell Histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study
47. Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan
48. Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: A retrospective study by the JACLS
49. Prospective monitoring of the Epstein–Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation
50. Unrelated donor marrow transplantation in children with severe aplastic anaemia using cyclophosphamide, anti-thymocyte globulin and total body irradiation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.